Multiple Assemblies exist for SMTL entry 6fe7
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-356; X-RAY DIFFRACTION 2.00 Å

	SMTL ID 6fe7.1 Ligands ZINC ION; MAGNESIUM ION; 1,2-ETHANEDIOL; DI(HYDROXYETHYL)ETHER; (4aS,8aR)-2-(1-{2-aminothieno[2,3-d]pyrimidin-4-yl}piperidin-4-yl)-4-(3,4- dimethoxyphenyl)-1,2,4a,5,8,8a-hexahydrophthalazin-1-one; 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID Polypeptides cAMP-specific 3',5'-cyclic phosphodiesterase 4D Oligo-state monomer
	SMTL ID 6fe7.2 Ligands ZINC ION; MAGNESIUM ION; 1,2-ETHANEDIOL; DI(HYDROXYETHYL)ETHER; 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID; (4aS,8aR)-2-(1-{2-aminothieno[2,3-d]pyrimidin-4-yl}piperidin-4-yl)-4-(3,4- dimethoxyphenyl)-1,2,4a,5,8,8a-hexahydrophthalazin-1-one Polypeptides cAMP-specific 3',5'-cyclic phosphodiesterase 4D Oligo-state monomer
	SMTL ID 6fe7.3 Ligands 1,2-ETHANEDIOL; TETRAETHYLENE GLYCOL; ZINC ION; MAGNESIUM ION; DI(HYDROXYETHYL)ETHER; 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID; (4aS,8aR)-2-(1-{2-aminothieno[2,3-d]pyrimidin-4-yl}piperidin-4-yl)-4-(3,4- dimethoxyphenyl)-1,2,4a,5,8,8a-hexahydrophthalazin-1-one Polypeptides cAMP-specific 3',5'-cyclic phosphodiesterase 4D Oligo-state monomer
	SMTL ID 6fe7.4 Ligands 1,2-ETHANEDIOL; ZINC ION; MAGNESIUM ION; DI(HYDROXYETHYL)ETHER; (4aS,8aR)-2-(1-{2-aminothieno[2,3-d]pyrimidin-4-yl}piperidin-4-yl)-4-(3,4- dimethoxyphenyl)-1,2,4a,5,8,8a-hexahydrophthalazin-1-one; 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID Polypeptides cAMP-specific 3',5'-cyclic phosphodiesterase 4D Oligo-state monomer